Latest updates on chronic viral hepatitis B

Ramazan IDILMAN; Fatih KARAKAYA

doi:https://doi.org/10.5472/MMJsi.2901.07

Makale detayları

Latest updates on chronic viral hepatitis B

Yazarlar:

Ramazan IDILMAN | Fatih KARAKAYA

Yayıncı:

Marmara University

Ana Başlıklar:

Hastalıklar

Dergi:

Marmara Medical Journal 2016 Vol.29 Issue 2, pp.33-37

Belge Tipi:

Makale

Yayın Tarihi:

7/2016

Belge Dili:

Türkçe

Document ID (Org No.):

2000544678

Sıklık:

Aylık

eISSN:

1309-9469

pISSN:

1019-1941

DOI:

https://doi.org/10.5472/MMJsi.2901.07

Özet:

 

Hepatitis B virus (HBV) remains a major cause of liver-relatedmorbidity and mortality in Turkey and all over the world. Twodifferent types of antiviral agents can be used in the treatmentof chronic hepatitis B (CHB). Conventional (IFN) or pegylatedinterferon alpha (PegIFN), nucleoside [lamivudine (LMV),telbivudine, emtricitabine, entecavir (ETV)] and nucleotide analogs[adefovir dipivoxil (ADV)] and tenofovir disoproxil fumarate(TDF)]. Antiviral agent must ensure a degree of HBV viralsuppression and will lead to biochemical, serological remissionand histological improvement. Current treatment strategies arediscussed in present brief report.Keywords: Chronic hepatitis B, Nucleos(t)ide analog, Entecavir,Tenofovir disoproxil fumarate.

 

Hepatitis B virus (HBV) remains a major cause of liver-relatedmorbidity and mortality in Turkey and all over the world. Twodifferent types of antiviral agents can be used in the treatmentof chronic hepatitis B (CHB). Conventional (IFN) or pegylatedinterferon alpha (PegIFN), nucleoside [lamivudine (LMV),telbivudine, emtricitabine, entecavir (ETV)] and nucleotide analogs[adefovir dipivoxil (ADV)] and tenofovir disoproxil fumarate(TDF)]. Antiviral agent must ensure a degree of HBV viralsuppression and will lead to biochemical, serological remissionand histological improvement. Current treatment strategies arediscussed in present brief report.Keywords: Chronic hepatitis B, Nucleos(t)ide analog, Entecavir,Tenofovir disoproxil fumarate.

Makale detayları

Latest updates on chronic viral hepatitis B

Yazarlar: Ramazan IDILMAN | Fatih KARAKAYA

Yayıncı: Marmara University

Ana Başlıklar: Hastalıklar

Dergi: Marmara Medical Journal 2016 Vol.29 Issue 2, pp.33-37

Belge Tipi: Makale

Yayın Tarihi: 7/2016

Belge Dili: Türkçe

Document ID (Org No.): 2000544678

Sıklık: Aylık

eISSN: 1309-9469

pISSN: 1019-1941

DOI: https://doi.org/10.5472/MMJsi.2901.07

Sayı

Yazarlar:

Ramazan IDILMAN | Fatih KARAKAYA

Yayıncı:

Marmara University

Ana Başlıklar:

Hastalıklar

Dergi:

Marmara Medical Journal 2016 Vol.29 Issue 2, pp.33-37

Belge Tipi:

Makale

Yayın Tarihi:

7/2016

Belge Dili:

Türkçe

Document ID (Org No.):

2000544678

Sıklık:

Aylık

eISSN:

1309-9469

pISSN:

1019-1941

DOI:

https://doi.org/10.5472/MMJsi.2901.07